Evidence map›Paper›PMID 31964880›Full record

ArticleNature communications2020

Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms.

Floriane Pelon, Brigitte Bourachot, Yann Kieffer, Ilaria Magagna, Fanny Mermet-Meillon, Isabelle Bonnet, Ana Costa, Anne-Marie Givel, Youmna Attieh, Jorge Barbazan and 8 more

Registry-linked trialOpen access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06666517 (The Relationship Between the Density of Cancer-Associated Fibroblasts in the Peritumoral Stroma and Clinicopathological Data in Breast Cancer Patients), which is not on this map. Cited by 243 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
243citing papers in PubMed, 1 pooled it
21.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06666517 nacompletednot on this mapstarted 2021, after this paper: background citation

The Relationship Between the Density of Cancer-Associated Fibroblasts in the Peritumoral Stroma and Clinicopathological Data in Breast Cancer Patients

TypeinterventionalSponsorHaydarpasa Numune Training and Research HospitalRan2021 to 2025Enrolled69ConditionsBreast CarcinomaArmssurgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines, Immunohistochemistry Analysis, Second Biopsy
3 · Its place in the literature

Who cites it

243 citing papers in PubMed, 1 synthesis or guideline pooled it, 370 citations in OpenAlex.

  1. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2021
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. GPX8Oncogene · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Challenges and advances in drug resistance and tolerance in cancer.Journal of experimental & clinical cancer research : CR · 2026
    Review
  16. Tumorigenesis and Tumor Microenvironment in Lung Cancer.Current issues in molecular biology · 2026
    Review
  17. Article
  18. Review
  19. Article
  20. Review

183 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Floriane PelonInstitut Curie, Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0003-2611-7728
Brigitte BourachotInstitut Curie, Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0001-7816-0539
Yann KiefferInstitut Curie, Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0003-2722-3071
Ilaria MagagnaInstitut Curie, Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0003-4092-5457
Fanny Mermet-MeillonAnalysis of Transduction Pathway, Institut Curie, Inserm, U830, PSL Research University, 26 rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0002-5114-2354
Isabelle BonnetInstitut Curie, Biology-inspired Physics at MesoScales Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, CNRS UMR168, PSL Research University, Sorbonne Université, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0003-2343-3784
Ana CostaInstitut Curie, Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0002-0893-3388
Anne-Marie GivelInstitut Curie, Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.
Youmna AttiehInstitut Curie, Cell Migration and Invasion, UMR144, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0003-1110-4991
Jorge BarbazanInstitut Curie, Cell Migration and Invasion, UMR144, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0002-7165-8497
Claire BonneauInstitut Curie, Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0001-6251-286X
Laetitia FuhrmannDepartment of Pathology, Institut Curie Hospital, 26, rue d'Ulm, F-75248, Paris, France.ORCID http://orcid.org/0000-0003-1755-6307
Stéphanie DescroixInstitut Curie, Laboratoire Physico Chimie Curie, Institut Pierre-Gilles de Gennes, CNRS UMR168, 75005, Paris, France.ORCID http://orcid.org/0000-0003-0027-352X
Danijela VignjevicInstitut Curie, Cell Migration and Invasion, UMR144, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0003-4250-703X
Pascal SilberzanInstitut Curie, Biology-inspired Physics at MesoScales Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, CNRS UMR168, PSL Research University, Sorbonne Université, 26, rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0002-8554-882X
Maria Carla ParriniAnalysis of Transduction Pathway, Institut Curie, Inserm, U830, PSL Research University, 26 rue d'Ulm, F-75005, Paris, France.ORCID http://orcid.org/0000-0002-7082-9792
Anne Vincent-SalomonDepartment of Pathology, Institut Curie Hospital, 26, rue d'Ulm, F-75248, Paris, France.
Fatima Mechta-GrigoriouInstitut Curie, Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France. fatima.mechta-grigoriou@curie.fr.ORCID http://orcid.org/0000-0002-3751-6989
Inserm · FRCentre National de la Recherche Scientifique · FRUniversité Paris Sciences et Lettres · FRInstitut Curie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although fibroblast heterogeneity is recognized in primary tumors, both its characterization in and its impact on metastases remain unknown. Here, combining flow cytometry, immunohistochemistry and RNA-sequencing on breast cancer samples, we identify four Cancer-Associated Fibroblast (CAF) subpopulations in metastatic lymph nodes (LN). Two myofibroblastic subsets, CAF-S1 and CAF-S4, accumulate in LN and correlate with cancer cell invasion. By developing functional assays on primary cultures, we demonstrate that these subsets promote metastasis through distinct functions. While CAF-S1 stimulate cancer cell migration and initiate an epithelial-to-mesenchymal transition through CXCL12 and TGFβ pathways, highly contractile CAF-S4 induce cancer cell invasion in 3-dimensions via NOTCH signaling. Patients with high levels of CAFs, particularly CAF-S4, in LN at diagnosis are prone to develop late distant metastases. Our findings suggest that CAF subset accumulation in LN is a prognostic marker, suggesting that CAF subsets could be examined in axillary LN at diagnosis.

Indexed as

AdultAgedAged, 80 and overAxillaBreast NeoplasmsCancer-Associated FibroblastsCell ProliferationCell SeparationChemokine CXCL12Epithelial-Mesenchymal TransitionFemaleFlow CytometryFollow-Up StudiesHumansKaplan-Meier EstimateLymphatic MetastasisChemokine CXCL12CXCL12 protein, humanReceptors, NotchTransforming Growth Factor beta

Identifiers

PMID31964880
PMCPMC6972713
OpenAlexW3002684299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.